CAPTRUST Financial Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-10,184
Closed -$41K – 2635
2025
Q2
$41K Buy
+10,184
New +$33.1K ﹤0.01% 2444
2024
Q4
– Sell
-11,671
Closed -$34.3K – 2302
2024
Q3
$34.3K Sell
11,671
-630
-5% -$2K ﹤0.01% 2251
2024
Q2
$42.8K Sell
12,301
-101
-0.8% -$337 ﹤0.01% 2154
2024
Q1
$35.3K Buy
+12,402
New +$38.3K ﹤0.01% 2098
2022
Q3
– Sell
-2,155
Closed -$10K – 2298
2022
Q2
$10K Sell
2,155
-85
-4% -$613 ﹤0.01% 3736
2022
Q1
$19K Buy
2,240
+285
+15% +$2K ﹤0.01% 3413
2021
Q4
$17K Hold
1,955
– – ﹤0.01% 3396
2021
Q3
$20K Hold
1,955
– – ﹤0.01% 3164
2021
Q2
$21K Hold
1,955
– – ﹤0.01% 3063
2021
Q1
$20K Buy
+1,955
New +$27.2K ﹤0.01% 2991

Other funds holding SRTA

CAPTRUST Financial Advisors's SRTA Position: Q3 2025 in Review

CAPTRUST Financial Advisors sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 10,184 shares — an estimated $41K sold.

CAPTRUST Financial Advisors first reported a position in SRTA in Q1 2021 and held it in 10 quarters. The position peaked at $42.8K in Q2 2024. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

  • CAPTRUST Financial Advisors reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,184 Strata Critical Medical Inc shares in Q3 2025, an estimated $41K.
  • CAPTRUST Financial Advisors first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Strata Critical Medical Inc position peaked at $42.8K in Q2 2024.
  • 137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2025, filed 19 Nov 2025.